JP-listed companies
RaQualia Pharma Inc.

RaQualia Pharma Inc.JP:4579

Market cap

¥12.2B

P/E ratio

Income statement Balance sheet Cash flow

	Dec 31, 2011	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023
Cash and deposits	-	4,890	4,035	1,904	1,840	1,428	2,268	1,671	2,174	1,394	2,345	3,675	3,715
Accounts receivable - trade, and contract assets	-	-	-	-	-	-	-	-	-	-	-	602	603
Securities	-	-	-	1,184	503	9	329	168	26	719	314	251	50
Supplies	-	-	-	-	7	7	5	6	6	7	11	8	146
Work in process	-	-	1	-	-	-	-	-	-	-	-	1	2
Supplies	-	-	-	-	7	7	5	6	6	7	11	8	146
Advance payments to suppliers	-	101	-	-	179	205	190	9	6	36	16	90	67
Advance payments to suppliers	-	101	-	-	179	205	190	9	6	36	16	90	67
Prepaid expenses	-	21	-	-	65	56	62	72	69	50	90	109	188
Prepaid expenses	-	21	-	-	65	56	62	72	69	50	90	109	188
Other	-	21	222	155	40	43	20	35	39	97	22	87	186
Other	-	21	222	155	40	43	20	35	39	97	22	87	186
Current assets	-	5,090	4,364	3,272	2,708	1,806	3,322	1,962	3,067	2,834	4,004	4,822	4,957
Current assets	-	5,090	4,364	3,272	2,708	1,806	3,322	1,962	3,067	2,834	4,004	4,822	4,957
Buildings	-	45	-	-	140	141	142	143	143	153	154	154	158
Tools, furniture and fixtures	-	418	370	349	394	452	488	677	742	872	944	964	1,125
Leased assets	-	-	-	-	-	-	-	3	3	49	60	255	398
Accumulated depreciation	-	-414	-464	-363	-273	-344	-415	-505	-639	-741	-859	-982	-1,107
Property, plant and equipment	-	101	7	85	261	249	216	318	249	333	299	391	574
Trademark right	-	2	4	4	2	6	5	5	5	4	4	4	5
Software	-	18	-	6	8	7	4	28	27	28	29	20	26
Other	-	1	8	4	4	0	1	1	1	1	1	0	0
Intangible assets	-	21	12	15	14	13	10	34	32	33	34	24	30
Intangible assets	-	21	12	15	14	13	10	34	32	33	34	24	30
Investment securities	-	476	2,221	1,800	1,752	1,937	1,503	1,717	1,474	1,038	888	988	1,231
Long-term prepaid expenses	-	4	-	-	5	3	2	10	2	0	0	24	64
Deferred tax assets	-	-	-	-	-	-	-	-	-	3	-	-	6
Long-term prepaid expenses	-	4	-	-	5	3	2	10	2	0	0	24	64
Other	-	70	45	43	12	11	11	12	12	10	9	8	11
Deferred tax assets	-	-	-	-	-	-	-	-	-	3	-	-	6
Investments and other assets	-	289	2,266	1,844	1,769	1,951	1,516	1,738	1,488	1,051	897	1,020	1,311
Other	-	70	45	43	12	11	11	12	12	10	9	8	11
Investments and other assets	-	289	2,266	1,844	1,769	1,951	1,516	1,738	1,488	1,051	897	1,020	1,311
Non-current assets	-	411	2,284	1,944	2,044	2,213	1,742	2,090	1,769	1,417	1,230	1,436	1,915
Assets	-	5,501	6,648	5,216	4,752	4,019	5,064	4,052	4,837	4,251	5,234	6,258	6,872
Accounts payable - trade	-	-	-	-	-	-	2	-	34	42	46	128	54
Current portion of long-term borrowings	-	-	-	-	-	-	-	-	-	-	-	3	13
Lease liabilities	-	-	-	-	-	-	-	1	1	18	22	43	64
Accounts payable - other	-	91	142	121	123	126	63	99	67	53	113	206	159
Accrued expenses	-	72	-	-	57	40	44	48	50	50	63	60	54
Income taxes payable	-	16	17	16	15	1	21	14	20	21	80	31	20
Deposits received	-	4	-	-	5	3	4	3	3	3	29	19	4
Other	-	-	74	144	-	5	-	-	-	-	10	4	22
Current liabilities	-	183	233	422	200	190	149	164	183	187	401	494	389
Long-term borrowings	-	-	-	-	-	-	-	-	-	-	-	9	39
Lease liabilities	-	-	-	-	-	-	-	2	2	27	18	168	252
Asset retirement obligations	-	-	-	-	12	12	12	12	12	12	12	12	12
Provision for share awards	-	-	-	-	-	-	-	-	-	-	-	61	48
Provision for share awards for directors (and other officers)	-	-	-	-	-	-	-	-	-	-	-	14	11
Deferred tax liabilities	-	-	-	-	-	-	-	-	19	14	16	3	-
Non-current liabilities	-	7	669	109	38	41	27	31	33	53	46	267	362
Liabilities	-	191	902	531	238	231	176	195	216	240	446	761	752
Share capital	-	8,490	8,628	8,952	9,806	2,238	2,741	2,793	2,255	2,255	2,257	2,266	2,668
Legal capital surplus	-	3,774	-	-	5,090	2,238	-	-	-	-	-	-	-
Capital surplus	-	3,774	3,912	4,236	5,090	2,238	2,931	2,983	2,445	2,445	2,447	2,455	2,857
Capital surplus	-	3,774	3,912	4,236	5,090	2,238	2,931	2,983	2,445	2,445	2,447	2,455	2,857
Retained earnings brought forward	-	-6,965	-	-	-10,421	-728	-	-	-	-	-	-	-
Retained earnings	-	-6,965	-8,074	-8,713	-10,421	-728	-786	-1,890	-99	-706	50	773	449
Retained earnings	-	-6,965	-8,074	-8,713	-10,421	-728	-786	-1,890	-99	-706	50	773	449
Treasury shares	-	-	-	-	-	-	-0	-0	-0	-0	-0	-0	-0
Shareholders' equity	-	5,298	4,466	4,476	4,475	3,747	4,887	3,886	4,600	3,994	4,753	5,494	5,974
Valuation difference on available-for-sale securities	-	12	1,247	199	28	26	-16	-42	8	5	24	-6	120
Valuation and translation adjustments	-	12	1,247	199	28	26	-16	-42	8	5	24	-6	120
Share acquisition rights	-	-	33	11	11	15	17	13	12	12	11	8	26
Net assets	8,174	5,310	5,746	4,686	4,514	3,789	4,888	3,857	4,621	4,011	4,788	5,497	6,120
Liabilities and net assets	-	5,501	6,648	5,216	4,752	4,019	5,064	4,052	4,837	4,251	5,234	6,258	6,872